IL1RL2 and cancer: In contrast to these cancers whereby IL-38 acts via suppression of the anti-tumour immune response, in a murine model of DMBA/TPA-induced squamous cell carcinomas (cSCC), IL-38 was shown to induce expression of inflammatory cytokines and drive proliferation and migration of cancer cells in an IL-36R-dependent manner.